Fibrolamellar Carcinoma of the Liver in a Child

References

• Edmondson H A. Differential diagnosis of tumors and tumorlike lesions of the liver in infancy and childhood. Am J Dis Child 1956; 91: 168–86
   PubMedGoogle Scholar
• Misugi K, Okajima H, Misugi N, Newton W A, Jr. Classification of primary malignant tumors of liver in infancy and childhood. Cancer 1967; 10: 1760–71
   Google Scholar
• Craig J R, Peters R L, Edmondson H A, Omata M. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 46: 372–9
   PubMed Web of Science ®Google Scholar
• Berman M M, Libbey N P, Foster J H. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma. An atypical variant with a favorable prognosis. Cancer 1980; 46: 1448–55
   PubMed Web of Science ®Google Scholar
• Stromeyer F W, Ishak K G, Berger M A, Mathew T. Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol 1980; 74: 254–8
   PubMed Web of Science ®Google Scholar
• Paradinas F J, et al. High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of heptatocellular carcinoma. Br Med J 1982; 285: 840–2
   PubMed Web of Science ®Google Scholar
• Lack E E, Neave C, Vawter G F. Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 1983; 52: 1510–15
   PubMed Web of Science ®Google Scholar
• Farhi D C, Shikes R H, Murari P J, Silverberg S G. Hepatocellular carcinoma in young people. Cancer 1983; 52: 1516–25
   PubMed Web of Science ®Google Scholar
• Tietelbaum D H, Tuttle S, Carey L C, Clausen K P. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg 1985; 202(1)36–41
   PubMed Web of Science ®Google Scholar
• Cabellero T, Aneiros J, Lopez-Caballero J, Gomez-Morales M, Nogales F. Fibrolamellär carcinoma. An immunohistochemical and ultrastructural study. Histopathology 1985; 9: 445–56
   PubMed Web of Science ®Google Scholar
• Lieberman J, Silton R M, Agliozzo C M, McMahon J. Hepatocellular carcinoma and intermediate alpha 1-antitrypsin deficiency (MZ phenotype). Am J Clin Pathol 1975; 64: 304–10
   PubMed Web of Science ®Google Scholar
• Rawlings W, Jr., Moss J, Cooper H S, Hamilton S R. Hepatocellular carcinoma and partial deficiency of alpha-1-antitrypsin (MZ). Ann Intern Med 1974; 81: 771–3
   PubMed Web of Science ®Google Scholar
• Vecchio F M, Fabiano A, Ghirlanda G, Manna R, Massi G. Fibrolamellar carcinoma of the liver: The malignant counterpart of focal nodular hyperplasia with oncocytic change. Am J Clin Pathol 1984; 81: 521–6
   PubMed Web of Science ®Google Scholar
• Fisher R L, Scheuer P J, Sherlock S. Primary liver cell carcinoma in the presence or absence of hepatitis B antigen. Cancer 1976; 38: 901–5
   PubMed Web of Science ®Google Scholar
• Wu P C, Lam K C. Cytoplasmic hepatitis B surface antigen and the ground-glass appearance in hepatocellular carcinoma. Am J Clin Pathol 1979; 71: 229–34
   PubMed Web of Science ®Google Scholar
• Landing B H. Tumors of the liver. Hepatocellular carcinoma, K Okuda, R L Peters. John Wiley, New York 1976; 205–26
   Google Scholar
• McFadzen A J, Yeung R T. Further observations on hypoglycemia in hepatocellular carcinoma. Am J Med 1969; 47: 220–35
   PubMed Web of Science ®Google Scholar
• McFadzean A J, Todd D, Tso S C. Erythrocytosis associated with hepatocellular carcinoma. Blood 1967; 29: 808–11
   PubMed Web of Science ®Google Scholar
• Becker D J, Sternberg M S, Kaiser M H. Hepatoma associated with hypoglycemia, polycythemia and hypercalcemia. JAMA 1963; 186: 1018–9
   PubMed Web of Science ®Google Scholar
• Heizberg J H, McPhee M S, Zarling E J, Lukert B P. Hepatocellular carcinoma: An unusual course with hyperthyroidism and inappropriate thyroid-stimulating hormone production. Gastroenterology 1985; 88: 181–4
   PubMed Web of Science ®Google Scholar
• Collier N A, Weinbren K, Bloom S R, Lee Y C, Hodgson H J, Blumgart L H. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1984; i: 538–40
   Google Scholar
• Nagorney D M, Adson M A, Weiland L H, Knith C D, Smalley S R, Zinsmeister A R. Fibrolamellar hepatoma. Am J Surg 1985; 149: 113–9
   PubMed Web of Science ®Google Scholar
• An T, Ghatak N, Kastener R, Kay S, Lee H M. Hyaline globules and intracellular lumina in a hepatocellular carcinoma. Am J Clin Pathol 1983; 79: 392–6
   PubMed Web of Science ®Google Scholar
• Schaff Z, Lapis K, Safranany L. The ultrastructure of primary hepatocellular carcinoma in man. Virchows Arch (A) 1971; 352: 340–58
   Web of Science ®Google Scholar
• Palmer P E, Wolfe H J. Alpha-1-antitrypsin deposition in primary hepatic carcinomas. Arch Pathol Lab Med 1976; 100: 232–6
   PubMed Web of Science ®Google Scholar
• Ordonez N G, Manning J T. Comparison of α-1-antitrypsin and α-1-antichymotrypsin in hepatocellular carcinoma: An immunoperoxidase study. Am J Gastroenterol 1984; 79: 959–63
   PubMed Web of Science ®Google Scholar
• Warner T F, Seo I S, Madura J A, Polak J M, Pearse A GE. Pancreatic-polypeptide-producing apudoma of the liver. Cancer 1980; 46: 1146–51
   PubMed Web of Science ®Google Scholar
• Xi Y P, Yu J Y. Primary neuroendocrine carcinoma of the liver. Ultrastruct Pathol 1986; 10: 331–6
   PubMed Web of Science ®Google Scholar
• Payne C M, Nagle R B, Paplanus S H, Graham A R, Berman M M. Fibrolamellar carcinoma of the liver: A primary malignant oncocytic carcinoid?. Ultrastruct Pathol 1986; 10: 539–52
   PubMed Web of Science ®Google Scholar
• Blumgart L H, Allison D J. Resection and embolisation in the management of secondary hepatic tumors. World J Surg 1982; 6: 32–45
   PubMed Web of Science ®Google Scholar
• Gould V E. Neuroendocrine tumors in “miscellaneous” primary sites: Clinical, pathologic and histogenetic implications. Prog Surg Pathol 1982; 4: 181–98
   Google Scholar
• Ali M, Fayemi O F, Braun E V. Malignant apudoma of the liver with symptomatic intractable hypoglycemia. Cancer 1978; 42: 686–92
   PubMed Web of Science ®Google Scholar
• Judge D M, Dickman P S, Trapukdi B S. Nonfunctioning argyrophilic tumor (APUDOMA) of the hepatic duct: Simplified methods of detecting biogenic amines in tissue. Am J Clin Pathol 1976; 66: 40–45
   PubMed Web of Science ®Google Scholar
• Barsky S H, Linnoila I, Triche T J, Costa J. Hepatocellular carcinoma with carcinoid features. Hum Pathol 1984; 15: 892–4
   PubMed Web of Science ®Google Scholar
• Weinberg A, Finegold M J. Primary hepatic tumors in childhood. Pathology of Neoplasia in Children and Adolescents. W. B. Saunders, Philadelphia 1986; 347–8, Chap 13, Vol 18 in Major Problems in Pathology
   Google Scholar